Detalles de la búsqueda
1.
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Cancers (Basel)
; 15(14)2023 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509217
2.
Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab.
Transl Lung Cancer Res
; 10(1): 355-367, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569318
3.
Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab.
J Geriatr Oncol
; 11(5): 807-813, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31937494
4.
Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.
Clin Lung Cancer
; 20(1): e97-e106, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30337270
5.
Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice.
Lung Cancer
; 133: 110-116, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200816
6.
Localized prostate cancer presenting as a renal pseudo-tumour.
Can Urol Assoc J
; 9(7-8): E505-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26279725
7.
Social media in cancer care: opportunities to improve care in locally advanced breast cancer.
Curr Opin Support Palliat Care
; 8(1): 77-82, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24270751
8.
Endobronchial hamartoma.
J Bronchology Interv Pulmonol
; 20(3): 247-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857199
Resultados
1 -
8
de 8
1
Próxima >
>>